Elsevier

Journal of Hepatology

Volume 57, Issue 2, August 2012, Pages 384-391
Journal of Hepatology

Research Article
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)

https://doi.org/10.1016/j.jhep.2012.03.024Get rights and content

Background & Aims

Non-alcoholic fatty liver disease (NAFLD) is a cardiovascular risk factor. Although modest alcohol consumption may reduce the risk for cardiovascular mortality, whether patients with NAFLD should be allowed modest alcohol consumption remains an important unaddressed issue. We aimed to evaluate the association between modest alcohol drinking and non-alcoholic steatohepatitis (NASH), among subjects with NAFLD.

Methods

In a cross-sectional analysis of adult participants in the NIH NASH Clinical Research Network, only modest or non-drinkers were included: participants identified as (1) drinking >20 g/day, (2) binge drinkers, or (3) non-drinkers with previous alcohol consumption were excluded. The odds of having a histological diagnosis of NASH and other histological features of NAFLD were analyzed using multiple ordinal logistic regression.

Results

The analysis included 251 lifetime non-drinkers and 331 modest drinkers. Modest drinkers compared to non-drinkers had lower odds of having a diagnosis of NASH (summary odds ratio 0.56, 95% CI 0.39–0.84, p = 0.002). The odds of NASH decreased as the frequency of alcohol consumption increased within the range of modest consumption. Modest drinkers also had significantly lower odds for fibrosis (OR 0.56 95% CI 0.41–0.77) and ballooning hepatocellular injury (OR 0.66 95% CI 0.48–0.92) than lifetime non-drinkers.

Conclusions

In a large, well-characterized population with biopsy-proven NAFLD, modest alcohol consumption was associated with lesser degree of severity as determined by lower odds of the key features that comprise a diagnosis of steatohepatitis, as well as fibrosis. These findings demonstrate the need for prospective studies and a coordinated consensus on alcohol consumption recommendations in NAFLD.

Introduction

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States (US) affecting as many as one third of adults [1]. Only a small subset of patients with NAFLD, namely those with a more severe subtype known as steatohepatitis (NASH), which is characterized by inflammatory infiltrates, ballooning hepatocellular injury, and fibrosis in addition to steatosis, are thought to be at risk for cirrhosis-related mortality.

The metabolic risk factors for NAFLD are also closely associated with coronary heart disease (CHD) [2]. Patients with NAFLD [3], and especially those with NASH [4], are at risk for coronary heart disease. Patients with NAFLD are approximately two times more likely to die from coronary heart disease than liver disease [5]. Therefore, management of CHD risk in patients with NAFLD is imperative. CHD risk can be modified through lifestyle changes, including diet, exercise, and smoking cessation. In addition, modest alcohol consumption has been shown to reduce the risk of coronary heart disease mortality and improve metabolic risk factors related to both coronary heart disease and NAFLD [6], [7]. As many as 50% of the adults in the United States regularly consume a modest amount of alcohol [8]. Excessive alcohol, however, can cause alcoholic liver disease [9]. In the general population, the daily threshold [10], [11], [12] of alcohol for liver injury is thought to be between 1–3 drinks per day in women and 2–3 in men. In patients with metabolic risk factors for NAFLD, the threshold may be lower [13]. Despite this, cross-sectional studies have suggested that modest alcohol consumption may protect the liver from NASH and NAFLD [14], [15]. The relationship between modest alcohol consumption and NAFLD severity has not been analyzed in detail. Whether patients with NAFLD should abstain from alcohol or be allowed modest alcohol consumption remains an important question. In practice, physicians often recommend abstinence from alcohol for patients with NAFLD, although the data to support this approach are lacking.

To provide counseling on alcohol consumption for patients with NAFLD, it is important to know whether modest alcohol consumption is associated with NAFLD disease severity. We hypothesize that modest alcohol consumption is associated with lower prevalence of NASH in patients with NAFLD. The primary aim of this study was to investigate a potential association between modest alcohol drinking and steatohepatitis in patients with NAFLD. Secondary aim was to test the association between modest alcohol drinking and the individual histological features of NAFLD including fibrosis.

Section snippets

Study sample

This was a cross-sectional study of the association between modest alcohol consumption and histological presence and/or severity of recognized lesions in NAFLD. We included baseline data from participants 21 years or older enrolled in two recently published NASH Clinical Research Network (CRN) studies: (1) a cohort study, the NAFLD Database [16]; and (2) a clinical trial, Pioglitazone versus Vitamin E versus Placebo for the Treatment of Non-diabetic Patients with Non-alcoholic Steatohepatitis

Study sample

The study sample included 252 lifetime non-drinkers and 331 modest drinkers enrolled in the NASH CRN studies with central pathology readings. The social, demographical, lifestyle, and metabolic characteristics of the two groups are presented in Table 1. As compared to lifetime non-drinkers, modest drinkers were more likely to be male, have higher income and education, have higher insulin sensitivity and HDL, and less likely to have diabetes.

Prevalence of histological features in lifetime non-drinkers and modest drinkers

The frequency and adjusted odds ratio for each

Discussion

We studied the association of modest alcohol consumption and steatohepatitis in a sample of well-characterized study participants with biopsy-proven NAFLD from referral centers across the US These data suggest that among subjects with biopsy-proven NAFLD, modest alcohol consumption up to two drinks per day was associated with half the odds of steatohepatitis. Modest drinkers also had a lesser severity of fibrosis and ballooning hepatocellular injury. Notably, a dose response was observed; among

Conclusions

In a large, well-characterized population with NAFLD, modest alcohol consumption was associated with significantly lower odds of biopsy-diagnosed NASH. Speculation regarding the role of modest alcohol consumption in prevention or treatment of NASH is tempting but premature. It is likely, however, that most non-cirrhotic patients with NAFLD who already drink modestly are not at risk for aggravating their liver disease. Whether a person with NAFLD should be abstinent or consume alcohol modestly

Conflict of interest

The underlying research reported in this study was funded by the NIH Institutes of Health.

Financial support

The Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN) is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Grants U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713), and the National Institute of Child Health and Human Development (NICHD). Several clinical centers use support from General Clinical Research Centers or Clinical and Translational Science Awards in conduct of

Acknowledgements

Members of the Non-alcoholic Steatohepatitis Clinical Research Network.

Baylor College of Medicine, Houston, TX:

Stephanie H. Abrams, MD, MS; Leanel Angeli Fairly, RN.

Case Western Reserve University Clinical Centers:

  • MetroHealth Medical Center, Cleveland, OH: Arthur J. McCullough, MD; Patricia Brandt; Diane Bringman, RN (2004–2008); Srinivasan Dasarathy, MD; Jaividhya Dasarathy, MD; Carol Hawkins, RN; Yao-Chang Liu, MD (2004–2009); Nicholette Rogers, PhD, PA-C (2004–2008); Margaret Stager, MD

References (34)

  • M.J. Davies et al.

    Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial

    JAMA

    (2002)
  • A.A. Howard et al.

    Effect of alcohol consumption on diabetes mellitus: a systematic review

    Ann Intern Med

    (2004)
  • [cited; Available from:...
  • M.J. Thun et al.

    Alcohol consumption and mortality among middle-aged and elderly US adults

    N Engl J Med

    (1997)
  • C.S. Fuchs et al.

    Alcohol consumption and mortality among women

    N Engl J Med

    (1995)
  • W. Dunn et al.

    Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease

    Hepatology

    (2008)
  • C.J. Neuschwander-Tetri BA et al.

    NASH Clinical Research Network. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

    Hepatology (Baltimore, Md)

    (2010)
  • Cited by (220)

    View all citing articles on Scopus

    For the Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN): NASH CRN Roster in Acknowledgements section.

    View full text